BWAY BrainsWay Ltd.

NASDAQ
$10.25

BrainsWay Ltd. (BWAY) is expected to report earnings on February 9, 2027, before the market open. The consensus earnings estimate is $0.13 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -7.7% since its last earnings release on November 10, 2026.

BrainsWay Missed Consensus Estimates, Sees Revenue Above Estimates
Tuesday, November 10, 2026 · 7:30 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 9
Tuesday · 7:30 AM ET
Earnings Whisper
-
vs $0.13
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $10.67

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BrainsWay Ltd.

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Charts powered in part by Lightweight Charts™ by TradingView.